2159-3337
Published by: Mary Ann Liebert, Inc. Publishers
https://home.liebertpub.com/publications/nucleic-acid-therapeutics/601/overview
| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Molecular Biology | 101 | 19 | 24 | 10 |
| Genetics | 106 | 12 | 19 | 9 |
| Biology and Biochemistry | 432 | 32 | 48 | 15 |
| Chemistry | 819 | 12 | 17 | 8 |
| Medicine | 2539 | 30 | 28 | 9 |
Nucleic Acid Therapeutics investigates studies in Oligonucleotide, Molecular biology, RNA, Aptamer and Cell biology. While Oligonucleotide is the focus of it, it also provided insights into the studies of Computational biology, Nucleic acid and Pharmacology. It addresses concerns in the field of Molecular biology by exploring it in line with topics in Cell culture which intersect with Cell growth subjects.
Small interfering RNA and RNA interference are all subfields of RNA research that were featured in the journal. While the primary focus in Nucleic Acid Therapeutics is Small interfering RNA, it also dissects topics surrounding Cancer research and Cancer and Metastasis as a whole. RNA interference research presented falls under the umbrella topic of Genetics.
The research on Aptamer tackled can also make contributions to studies in the areas of SELEX Aptamer Technique, Systematic evolution of ligands by exponential enrichment, Cancer cell, Biophysics and DNA. The journal tackles studies in Gene silencing and the interrelated subject of microRNA to gain insights into Cell biology. Biochemistry works presented in the journal have a specific focus on Plasma protein binding.
The journal articles generally zeroe in on subjects such as Oligonucleotide, RNA, Molecular biology, Computational biology and Aptamer. The journal publications with studies in Oligonucleotide featured incorporate elements of Nucleic acid and Pharmacology. The most cited articles explore issues in RNA which can be linked to other research areas like Messenger RNA, In vivo and Nuclease.
The main research concerns discussed in the journal are RNA, Oligonucleotide, Cell biology, Antisense oligonucleotides and Computational biology. The research on RNA featured in Nucleic Acid Therapeutics combines topics in other fields like Gene silencing, In vivo and Folate receptor. The research topics discussed in it include Oligonucleotide as well as Stable Isotope Labeling.
Nucleic Acid Therapeutics holds forums on Cell biology that merges themes from other disciplines such as Gene knockdown, Exon skipping, Downregulation and upregulation, Duchenne muscular dystrophy and Exon. It explores research in Computational biology alongside concepts in Nucleic acid and other areas of study in Gene expression, Hepatocyte and Drug delivery. Some problems in Small interfering RNA that were presented in it overlapped with concepts under Biophysics, RNA interference and Ligand (biochemistry).
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Nucleic Acid Therapeutics (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Nucleic Acid Therapeutics (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 11.36% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 28.21% were posted by at least one author from the top 10 institutions publishing in the journal. Another 12.82% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 20.51% of all publications and 38.46% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
Wesley Tyler Abplanalp;Ariane Fischer;David John;Andreas M Zeiher
(2020)Annemieke Aartsma-Rus;David R. Corey
(2020)Laurent Servais;Laurent Servais;Eugenio Mercuri;Volker Straub;Michela Guglieri
(2021)Erle M Holgersen;Shreshth Gandhi;Yongchao Zhou;Jinkuk Kim
(2021)For those interested in healthcare but not ready to commit to medical school, there are several valuable online programs that can pave alternative career pathways. Students seeking a tech-focused role might consider pursuing online rad tech programs, which offer affordable and flexible routes to becoming a radiologic technologist.
Nutrition and wellness sectors are growing rapidly, making best dietitian programs a popular choice for those wanting to specialize in dietetics. These master's level programs often accommodate working professionals looking to advance their education online.
Starting a healthcare career can also be accessible through medical assistant classes online with financial aid. Such programs offer hands-on skills training paired with financial support to make healthcare education more attainable.
For medical assistants aiming to elevate their credentials, the ma to lpn bridge program provides a streamlined path to becoming a licensed practical nurse (LPN) through online coursework combined with clinical experiences.
